Clinical Trials Logo

Vomiting clinical trials

View clinical trials related to Vomiting.

Filter by:

NCT ID: NCT01617837 Completed - Clinical trials for Postoperative Nausea and Vomiting

The Efficacy of P6 Acupressure in Reducing Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy

Start date: November 2011
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this study is to investigate if P6 acupressure may reduce postoperative nausea and vomiting in neurosurgical patients undergoing craniotomy.

NCT ID: NCT01602692 Completed - Pain, Postoperative Clinical Trials

A Comparison of Tumescence in Breast Reduction Surgery

Start date: August 2012
Phase: Phase 4
Study type: Interventional

The investigators' main hypothesis is that in breast reduction surgery, the use of tumescent solution containing both dilute lidocaine and epinephrine will lead to better control of postoperative pain, nausea, vomiting, shorter time through postoperative phases of care, quicker discharge from the hospital and lower numbers of hospital readmissions than the use of tumescent solution containing only dilute epinephrine.

NCT ID: NCT01596400 Completed - Clinical trials for Chemotherapy Induced Nausea and Vomiting

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

Start date: May 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the dosing strategy for adolescents aged 13 to 17 years.

NCT ID: NCT01594749 Completed - Clinical trials for Chemotherapy-Induced Nausea and Vomiting (CINV)

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)

Start date: September 24, 2012
Phase: Phase 3
Study type: Interventional

This study aims to demonstrate that, when given concomitantly with a 5-hydroxytryptamine 3 (5-HT3) antagonist and a corticosteroid, a single 150 mg intravenous (IV) dose of fosaprepitant given on Day 1 is superior to the control regimen of 5-HT3 antagonist and corticosteroid only, in preventing chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC).

NCT ID: NCT01592708 Completed - Clinical trials for Post-operative Nausea

Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery

Start date: June 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a multi-modal anesthesia and pain control protocol reduces post-operative and post-discharge nausea and vomiting (PONV and PDNV) in patients undergoing upper jaw corrective surgery.

NCT ID: NCT01590147 Completed - Pain Clinical Trials

Supportive Intervention Programs Study

SIPS
Start date: June 2011
Phase: N/A
Study type: Interventional

This randomized clinical trial studies the preliminary efficacy of a yoga skills training (YST) compared to counseling and education (CE) for reducing treatment-related symptoms in patients with colorectal cancer who are receiving chemotherapy. The YST may reduce fatigue, other treatment-related symptoms, and improve the quality of life (QOL) of patients with colorectal cancer. It is not yet known whether YST is more effective then CE in reducing these outcomes.

NCT ID: NCT01575600 Completed - Clinical trials for Postoperative Vomiting

Effect of Intravenous Fluid Therapy on Postoperative Vomiting in Children Undergoing Otorhinolaryngological Surgery

Start date: July 2010
Phase: Phase 3
Study type: Interventional

The purpose of this randomized clinical trial is to evaluate the interaction of intravenous fluid therapy during otorhinolaryngological surgery, on postoperative vomiting. The hypothesis is that perioperative supplemental intravenous fluid administration reduces the incidence of postoperative vomiting.

NCT ID: NCT01568268 Completed - General Anesthesia Clinical Trials

Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting

Start date: January 2012
Phase: Phase 3
Study type: Interventional

This study was designed to evaluate the treatment efficacy and safety of palonosetron for the patients who undergo laparoscopic gynecologic, abdominal or other surgery under general anesthesia.

NCT ID: NCT01556932 Completed - Nausea Clinical Trials

Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea

Start date: March 2012
Phase: N/A
Study type: Interventional

This randomized clinical trial studies ABH (lorazepam, diphenhydramine hydrochloride, and haloperidol) gel in patients with nausea. ABH gel, when absorbed into the skin, may be an effective treatment for nausea and vomiting. The general purpose of this research study is to improve the treatment of nausea and vomiting.

NCT ID: NCT01553578 Completed - Pain Clinical Trials

Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemotherapy

Start date: February 2012
Phase: N/A
Study type: Interventional

This randomized clinical trial studies healing touch or guided imagery in treating pain, fatigue, nausea, and anxiety in patients undergoing chemotherapy. Healing touch and guided imagery may help treat complications caused by chemotherapy. It is not yet known whether healing touch or guided imagery is more effective in treating pain, fatigue, nausea, and anxiety in patients undergoing chemotherapy